Bruker Daltonics Announces Selection of its RAID(TM)-XP Chemical Agent and Radiation Detector for Wheeled Armored Vehicles of the Czech Army.BILLERICA, Mass. -- Bruker Daltonics today announces a $4.0 million contract award for its RAID[TM]-XP man-portable chemical agent and radiation detector from Steyr-Daimler-Puch Spezialfahrzeug GmbH. The Bruker RAID-XP instruments will be integrated into Steyr's Pandur wheeled armored vehicles to be delivered to the Czech Army. The primary mission of the instruments, which will be delivered over a period of several years, is the protection of crew members against chemical agents and gamma radiation. Of course, the RAID-XP can also be removed from the vehicle for man-portable missions. Mr. Sebastian Meyer-Plath, Bruker Daltonics' Vice President for Chemical, Biological, Nuclear and Radiation (CBRN CBRN Chemical, Biological, Radiological, and Nuclear CBRN Caribbean Basin Radar Network ) detection, commented: "We are very pleased with this selection by the Czech Army and Steyr. This RAID-XP contract is the first in the field of nuclear and chemical detection in non-CBRN-dedicated wheeled armored vehicles. We endeavour to be responsive to new user requirements and our unique RAID-XP concept for simultaneous chemical and nuclear detection in a single instrument is quickly becoming a preferred solution for dedicated CBRN teams, as well as for general NC defense and homeland security applications." Bruker Daltonics' robust RAID- XP NC detector combines radiological and chemical detection into one system based on the Company's RAID-M cutting-edge IMS (1) See IP Multimedia Subsystem. (2) (Information Management System) An early IBM hierarchical DBMS for IBM mainframes. IMS was widely implemented throughout the 1970s under MVS and continues to be used under z/OS. technology for chemical detection, and the advanced SVG (Scalable Vector Graphics) A vector graphics format from the W3C for the Web that is expressed in XML. Introduced in 2001, SVG was designed to become the standard vector format just as GIFs and JPEGs have become the standard bitmaps for the Web. 2 technology for detection of gamma radiation. Equipped with a data-logger and GPS connectivity, the RAID-XP operates in both stationary and mobile mode, and can also be integrated into sensor networks. ABOUT BRUKER BIOSCIENCES (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : BRKR BRKR Breaker ) Bruker BioSciences Corporation Bruker Biosciences Corporation is a Massachusetts-based company formed in 2003 which develops and manufactures scientific instrumentation for academic research and industrial use. , headquartered in Billerica, Massachusetts, is the publicly traded parent company of Bruker Daltonics Inc., Bruker AXS Inc. and Bruker Optics Inc. For more information, please visit www.bruker-biosciences.com * Bruker AXS is a leading developer and provider of advanced X-ray tools used primarily in life science and materials research, as well as of X-ray and OES elemental analysis instrumentation used primarily in industrial applications. * Bruker Daltonics is a leading developer and provider of innovative life science tools based on mass spectrometry mass spectrometry or mass spectroscopy Analytic technique by which chemical substances are identified by sorting gaseous ions by mass using electric and magnetic fields. and also develops and provides a broad range of field analytical systems for chemical, biological, radiological and nuclear detection. * Bruker Optics is a leading developer and provider of research, analytical and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technology. BRUKER BIOSCIENCES CAUTIONARY STATEMENT Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to our reorganization strategies, risks related to the integration of businesses we have acquired or may acquire in the future, technological approaches, product development, market acceptance, cost and pricing of our products, changes in governmental regulations, capital spending capital spending Spending for long-term assets such as factories, equipment, machinery, and buildings that permits the production of more goods and services in future years. and government funding policies, FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. and other regulatory approvals to the extent applicable, competition, the intellectual property of others, patent protection and litigation An action brought in court to enforce a particular right. The act or process of bringing a lawsuit in and of itself; a judicial contest; any dispute. When a person begins a civil lawsuit, the person enters into a process called litigation. . These and other factors are identified and described in more detail in our filings with the SEC, including, without limitation, our annual report on Form 10-K for the year ended December 31, 2005, our most recent quarterly reports on Form 10-Q and, our current reports on Form 8-K. We disclaim any intent or obligation to update these forward-looking statements. |
|
Printer friendly
Cite/link
Email
Feedback
Reader Opinion